Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_assertion type Assertion NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_head.
- NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_assertion description "[In particular, ASXL1 mutations are common in patients with hematologic malignancies associated with myelodysplasia, including myelodysplastic syndromes (MDSs), and chronic myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_provenance.
- NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_assertion evidence source_evidence_literature NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_provenance.
- NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_assertion SIO_000772 24216483 NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_provenance.
- NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_assertion wasDerivedFrom befree-20150227 NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_provenance.
- NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_assertion wasGeneratedBy ECO_0000203 NP978571.RAMh7jNjxIZ2-mYf1YUUs-UEmVXFR-h5zaEsDioFooYpo130_provenance.